With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and bio...
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from early-stage development to scale-up & commercial manufacture of high potent APIs with occupational exposure limits (OEL) down to 0.1g/m³/shift (OEB class 5). In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally. We have a proven track record in our capability to take projects from early stage through to commercial production. We operate three FDA inspected sites in France and Belgium.
KEY PRODUCTS
LIST
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Drugs in Development
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
CDMO (API & HPAPI)/ Generics/ Security of supply/ Regulatory submission expertise/ Track record performance/ FDA & GMP
